New York, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global 3D Cell Culture Industry" - https://www.reportlinker.com/p05797741/?utm_source=GNW
1 Million in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 13.7% over the analysis period 2020-2027.Scaffold-based, one of the segments analyzed in the report, is projected to grow at a 13.9% CAGR to reach US$1.1 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Scaffold-free segment is readjusted to a revised 13.1% CAGR for the next 7-year period. This segment currently accounts for a 27.2% share of the global 3D Cell Culture market.
The U.S. Accounts for Over 35.1% of Global Market Size in 2020, While China is Forecast to Grow at a 14.8% CAGR for the Period of 2020-2027
The 3D Cell Culture market in the U.S. is estimated at US$341.2 Million in the year 2020. The country currently accounts for a 35.1% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$161.4 Million in the year 2027 trailing a CAGR of 14.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.3% and 11.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR while Rest of European market (as defined in the study) will reach US$161.4 Million by the year 2027.
Microfluidics-based Segment Corners a 17.1% Share in 2020
In the global Microfluidics-based segment, USA, Canada, Japan, China and Europe will drive the 15.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$139.1 Million in the year 2020 will reach a projected size of US$377.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$186.4 Million by the year 2027.
Select Competitors (Total 38 Featured)
- 3D Biotek, LLC
- Advanced Biomatrix, Inc.
- Becton Dickinson and Company
- Corning Inc.
- Greiner Bio One International GmbH
- Hamilton Company
- InSphero AG
- Lonza Group AG
- Merck KGaA
- Mimetas B.V.
- Nanofiber Solutions
- REPROCELL USA Inc.
- Synthecon, Incorporated
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
Read the full report: https://www.reportlinker.com/p05797741/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
3D Cell Culture Transforms Life Sciences Industry
3D Cell Culture: An Introduction
3D-Cell Culture Models
Benefits of 3D Cell Culture
Key 3D Cell Culture Formats
3D Cell Culture?Different Techniques
Scaffold-Based 3D Cell Culture
Polymeric Hard Scaffolds
Biological Scaffolds
Micropatterned Surface Microplates
Non-Scaffold Based 3D Cell Culture
Hanging Drop Microplates
Spheroid Microplates with Ultra-Low Attachment (ULA) coating
Microfluidic 3D Cell Culture
Expanding Applications Fuel Growth in the Global 3D Cell
Culture Market
Developed Regions Lead the 3D Cell Culture Market, Asia-Pacific
to Register Faster Growth
Scaffold-based 3D Cell Culture Products Dominate the Market
Cancer and Stem Cell Research Leads the Global Market
Competitive Scenario
Key Commercial 3D Cell Culture Devices
2. FOCUS ON SELECT PLAYERS
Recent Market Activity
3. MARKET TRENDS & DRIVERS
Rising Incidence of Cancer Drives the Demand for 3D Cell Culture
EXHIBIT 1: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 2: Global Number of New Cancer Cases and Cancer-related
Deaths by Cancer Site for 2018
EXHIBIT 3: Number of New Cancer Cases and Deaths (in Million)
by Region for 2018
Increasing Demand for 3D Cell Culture in Drug Discovery
Use of 3D Cell Culture for Regenerative Medicine
Organoids as Alternatives to Using Animals in Experiments
Use of 3D Cell Culture for Regenerative Medicine
Microfluidic Chips Hold Potential in Addressing 3D Cell Culture
Challenges
Technological Advancements Promote 3D Cell Culture Market
Researchers Use Lab-on-a-CD Technology to Generate Spheroid 3D
Cell Cultures
3D Bioprinting Holds Potential to Revolutionize Organ
Transplantation Space
A Review of Research Efforts and Achievements of Companies and
Universities
3D Tissue Culture: Growing Significance in Cancer Research
Cells Grown in 3D Change Cell Proliferation and Morphology
Cells Grown in 3D Demonstrate a More Pragmatic Drug Response
Cells Grown in 3D Express Phenotypic Heterogeneity
Cells Grown in 3D Alter Cell Behavior and Gene Expression
Cells Grown in 3D Replicate the Tumor Microenvironment
Other Advantages of 3D Tissue Culture Models
New Dimension of Cell Culture: The Rise of Spheroid Culture
Systems
Challenges
Progress in Scaffolds and Hydrogels Aids Creation of Organoids
and Spheroids
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for 3D Cell Culture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 2: World Historic Review for 3D Cell Culture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2017 through 2019 and
% CAGR
Table 3: World 10-Year Perspective for 3D Cell Culture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2017, 2020 & 2027
Table 4: World Current & Future Analysis for Scaffold-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 5: World Historic Review for Scaffold-based by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2017 through 2019 and % CAGR
Table 6: World 10-Year Perspective for Scaffold-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2017, 2020 & 2027
Table 7: World Current & Future Analysis for Scaffold-free by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 8: World Historic Review for Scaffold-free by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2017 through 2019 and % CAGR
Table 9: World 10-Year Perspective for Scaffold-free by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2017, 2020 & 2027
Table 10: World Current & Future Analysis for
Microfluidics-based by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for Microfluidics-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2017 through 2019 and
% CAGR
Table 12: World 10-Year Perspective for Microfluidics-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2017, 2020 & 2027
Table 13: World Current & Future Analysis for Magnetic &
Bioprinted by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 14: World Historic Review for Magnetic & Bioprinted by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2017 through 2019 and
% CAGR
Table 15: World 10-Year Perspective for Magnetic & Bioprinted
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2017, 2020 & 2027
Table 16: World Current & Future Analysis for Cancer & Stem
Cell Research by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 17: World Historic Review for Cancer & Stem Cell Research
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2017 through 2019 and
% CAGR
Table 18: World 10-Year Perspective for Cancer & Stem Cell
Research by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2017, 2020 & 2027
Table 19: World Current & Future Analysis for Drug Discovery &
Toxicology Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 20: World Historic Review for Drug Discovery & Toxicology
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2017 through
2019 and % CAGR
Table 21: World 10-Year Perspective for Drug Discovery &
Toxicology Testing by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2017, 2020 & 2027
Table 22: World Current & Future Analysis for Tissue
Engineering & Regenerative Medicine by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Tissue Engineering &
Regenerative Medicine by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2017 through 2019 and % CAGR
Table 24: World 10-Year Perspective for Tissue Engineering &
Regenerative Medicine by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2017, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 25: USA Current & Future Analysis for 3D Cell Culture by
Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 26: USA Historic Review for 3D Cell Culture by Product -
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2017 through 2019 and % CAGR
Table 27: USA 10-Year Perspective for 3D Cell Culture by
Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 28: USA Current & Future Analysis for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 29: USA Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 30: USA 10-Year Perspective for 3D Cell Culture by
Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
CANADA
Table 31: Canada Current & Future Analysis for 3D Cell Culture
by Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 32: Canada Historic Review for 3D Cell Culture by Product -
Scaffold-based, Scaffold-free, Microfluidics-based and
Magnetic & Bioprinted Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Table 33: Canada 10-Year Perspective for 3D Cell Culture by
Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 34: Canada Current & Future Analysis for 3D Cell Culture
by Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 35: Canada Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 36: Canada 10-Year Perspective for 3D Cell Culture by
Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
JAPAN
Table 37: Japan Current & Future Analysis for 3D Cell Culture
by Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 38: Japan Historic Review for 3D Cell Culture by Product -
Scaffold-based, Scaffold-free, Microfluidics-based and
Magnetic & Bioprinted Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Table 39: Japan 10-Year Perspective for 3D Cell Culture by
Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 40: Japan Current & Future Analysis for 3D Cell Culture
by Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 41: Japan Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 42: Japan 10-Year Perspective for 3D Cell Culture by
Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
CHINA
Table 43: China Current & Future Analysis for 3D Cell Culture
by Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 44: China Historic Review for 3D Cell Culture by Product -
Scaffold-based, Scaffold-free, Microfluidics-based and
Magnetic & Bioprinted Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Table 45: China 10-Year Perspective for 3D Cell Culture by
Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 46: China Current & Future Analysis for 3D Cell Culture
by Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 47: China Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 48: China 10-Year Perspective for 3D Cell Culture by
Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
EUROPE
Table 49: Europe Current & Future Analysis for 3D Cell Culture
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 50: Europe Historic Review for 3D Cell Culture by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 51: Europe 10-Year Perspective for 3D Cell Culture by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2017, 2020 & 2027
Table 52: Europe Current & Future Analysis for 3D Cell Culture
by Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 53: Europe Historic Review for 3D Cell Culture by Product -
Scaffold-based, Scaffold-free, Microfluidics-based and
Magnetic & Bioprinted Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Table 54: Europe 10-Year Perspective for 3D Cell Culture by
Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 55: Europe Current & Future Analysis for 3D Cell Culture
by Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 56: Europe Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 57: Europe 10-Year Perspective for 3D Cell Culture by
Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
FRANCE
Table 58: France Current & Future Analysis for 3D Cell Culture
by Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 59: France Historic Review for 3D Cell Culture by Product -
Scaffold-based, Scaffold-free, Microfluidics-based and
Magnetic & Bioprinted Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Table 60: France 10-Year Perspective for 3D Cell Culture by
Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 61: France Current & Future Analysis for 3D Cell Culture
by Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 62: France Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 63: France 10-Year Perspective for 3D Cell Culture by
Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
GERMANY
Table 64: Germany Current & Future Analysis for 3D Cell Culture
by Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 65: Germany Historic Review for 3D Cell Culture by
Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2017 through 2019 and %
CAGR
Table 66: Germany 10-Year Perspective for 3D Cell Culture by
Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 67: Germany Current & Future Analysis for 3D Cell Culture
by Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 68: Germany Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 69: Germany 10-Year Perspective for 3D Cell Culture by
Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
ITALY
Table 70: Italy Current & Future Analysis for 3D Cell Culture
by Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 71: Italy Historic Review for 3D Cell Culture by Product -
Scaffold-based, Scaffold-free, Microfluidics-based and
Magnetic & Bioprinted Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Table 72: Italy 10-Year Perspective for 3D Cell Culture by
Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 73: Italy Current & Future Analysis for 3D Cell Culture
by Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 74: Italy Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 75: Italy 10-Year Perspective for 3D Cell Culture by
Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
UNITED KINGDOM
Table 76: UK Current & Future Analysis for 3D Cell Culture by
Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 77: UK Historic Review for 3D Cell Culture by Product -
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2017 through 2019 and % CAGR
Table 78: UK 10-Year Perspective for 3D Cell Culture by Product -
Percentage Breakdown of Value Sales for Scaffold-based,
Scaffold-free, Microfluidics-based and Magnetic & Bioprinted
for the Years 2017, 2020 & 2027
Table 79: UK Current & Future Analysis for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 80: UK Historic Review for 3D Cell Culture by Application -
Cancer & Stem Cell Research, Drug Discovery & Toxicology
Testing and Tissue Engineering & Regenerative Medicine Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2017 through 2019 and % CAGR
Table 81: UK 10-Year Perspective for 3D Cell Culture by
Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
REST OF EUROPE
Table 82: Rest of Europe Current & Future Analysis for 3D Cell
Culture by Product - Scaffold-based, Scaffold-free,
Microfluidics-based and Magnetic & Bioprinted - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 83: Rest of Europe Historic Review for 3D Cell Culture by
Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2017 through 2019 and %
CAGR
Table 84: Rest of Europe 10-Year Perspective for 3D Cell
Culture by Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 85: Rest of Europe Current & Future Analysis for 3D Cell
Culture by Application - Cancer & Stem Cell Research, Drug
Discovery & Toxicology Testing and Tissue Engineering &
Regenerative Medicine - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 86: Rest of Europe Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 87: Rest of Europe 10-Year Perspective for 3D Cell
Culture by Application - Percentage Breakdown of Value Sales
for Cancer & Stem Cell Research, Drug Discovery & Toxicology
Testing and Tissue Engineering & Regenerative Medicine for the
Years 2017, 2020 & 2027
ASIA-PACIFIC
Table 88: Asia-Pacific Current & Future Analysis for 3D Cell
Culture by Product - Scaffold-based, Scaffold-free,
Microfluidics-based and Magnetic & Bioprinted - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 89: Asia-Pacific Historic Review for 3D Cell Culture by
Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2017 through 2019 and %
CAGR
Table 90: Asia-Pacific 10-Year Perspective for 3D Cell Culture
by Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 91: Asia-Pacific Current & Future Analysis for 3D Cell
Culture by Application - Cancer & Stem Cell Research, Drug
Discovery & Toxicology Testing and Tissue Engineering &
Regenerative Medicine - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 92: Asia-Pacific Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 93: Asia-Pacific 10-Year Perspective for 3D Cell Culture
by Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
REST OF WORLD
Table 94: Rest of World Current & Future Analysis for 3D Cell
Culture by Product - Scaffold-based, Scaffold-free,
Microfluidics-based and Magnetic & Bioprinted - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 95: Rest of World Historic Review for 3D Cell Culture by
Product - Scaffold-based, Scaffold-free, Microfluidics-based
and Magnetic & Bioprinted Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2017 through 2019 and %
CAGR
Table 96: Rest of World 10-Year Perspective for 3D Cell Culture
by Product - Percentage Breakdown of Value Sales for
Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic &
Bioprinted for the Years 2017, 2020 & 2027
Table 97: Rest of World Current & Future Analysis for 3D Cell
Culture by Application - Cancer & Stem Cell Research, Drug
Discovery & Toxicology Testing and Tissue Engineering &
Regenerative Medicine - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 98: Rest of World Historic Review for 3D Cell Culture by
Application - Cancer & Stem Cell Research, Drug Discovery &
Toxicology Testing and Tissue Engineering & Regenerative
Medicine Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2017 through 2019 and % CAGR
Table 99: Rest of World 10-Year Perspective for 3D Cell Culture
by Application - Percentage Breakdown of Value Sales for Cancer &
Stem Cell Research, Drug Discovery & Toxicology Testing and
Tissue Engineering & Regenerative Medicine for the Years 2017,
2020 & 2027
IV. COMPETITION
Total Companies Profiled: 38
Read the full report: https://www.reportlinker.com/p05797741/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
